Author

Qing-Liang Li

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Oct 2026

Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China

ABSTRACT Co-administration of vaccines targeting multiple respiratory pathogens may enhance coverage and streamline adult immunization programs. We conducted a randomized, multicentre, open-label Phase IV trial registered at Chinese Clinical Trial Registry (ChiCTR2100046227) in China to evaluate the immunogenicity and...

Xuan-Wen Shi, Sha-Sha Han, Cong Wu et al. · Human Vaccines & Immunothera... · 0 citations

Open access Sep 2026

Safety and cross-neutralization capacity of a Sabin strain-based inactivated polio vaccine: a randomized, double-blind, positive-control clinical trial in 2-month-old infants

The findings suggest that the broad cross-neutralization capacity and favorable safety profile of test-sIPV suggest that it could play a valuable role in global polio eradication strategies, particularly in developing countries transitioning from OPV to affordable IPV-based immunization schedules.

Wei-Wei Lu, Lei Zhao, Zhong-Yang Zhang et al. · BMC Infectious Diseases · 0 citations